Relationship between the efficacy of inhaled corticosteroids and the leukotriene expression in children with asthma

WU Jie-Ling, CHEN Ai-Huan, PENG Qiu-Ying, CHEN Rong-Chang, ZHONG Nan-Shan

Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (06) : 441-444.

PDF(1037 KB)
PDF(1037 KB)
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (06) : 441-444.
CLINICAL RESEARCH

Relationship between the efficacy of inhaled corticosteroids and the leukotriene expression in children with asthma

  • WU Jie-Ling, CHEN Ai-Huan, PENG Qiu-Ying, CHEN Rong-Chang, ZHONG Nan-Shan.
Author information +
History +

Abstract

OBJECTIVE: To evaluate the relationship between leukotriene expression in blood polymorphonuclear leukocytes (PMNL) and the efficacy of inhaled corticosteroids (ICS) in children with asthma. METHODS: Thirty-two children with asthma (5-12 years) and ten healthy children (control group) were enrolled. The asthmatic children were subdivided into ICS well-controlled and ICS poorly-controlled groups based on their clinical symptoms and lung function. The level of leukotriene C4 synthase (LTC4S) mRNA in PMNL was detected by fluorescence quantitative polymerase chain reaction. The level of LTC4S mRNA was expressed by the value of qCt, and the value of qCt was diversely correlated with the level of LTC4S mRNA expression. The concentration of urinary leukotriene E4 (LTE4) was measured using ELISA. RESULTS: The expression of LTC4S mRNA in PMNL was significantly higher in children with asthma (qCt: 1.12±0.27) than that in the control group (qCt: 1.42±0.12;P<0.05). The expression of LTC4S mRNA in PMNL in the ICS poorly-controlled group (qCt: 1.03±0.17) was significantly higher than that in the ICS well-controlled group (qCt: 1.24±0.33; P<0.05) and the control group(1.42±0.12;P<0.01). There was no significant difference in the level of urinary LTE4 among the the ICS poorly-controlled, the ICS well-controlled and the control groups. CONCLUSIONS: LTC4S mRNA expression in PMNL in asthmatic children increases, and the LTC4S mRNA expression in the ICS poorly-controlled group is higher than that in the ICS well-controlled group. This suggests that an increased leukotriene expression might be associated with poorly-controlled asthma.[Chin J Contemp Pediatr, 2009, 11 (6):441-444]

Key words

Asthma / leukotriene / Inhaled corticosteroid / Child

Cite this article

Download Citations
WU Jie-Ling, CHEN Ai-Huan, PENG Qiu-Ying, CHEN Rong-Chang, ZHONG Nan-Shan. Relationship between the efficacy of inhaled corticosteroids and the leukotriene expression in children with asthma[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(06): 441-444

References

[1] Dworski R, Fitzgerald GA, Oates JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma [J]. Am J Respir Crit Care Med, 1994, 149(4 Pt 1): 953-959.
[2]O′Shaughnessy KM, Wellings R, Gillies B, Fuller RW. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion [J]. Am Rev Respir Dis, 1993, 147(6 Pt 1): 1472-1476.
[3]中华医学会儿科学分会呼吸学组.儿童支气管哮喘防治常规(试行) [J].中华儿科杂志, 2004, 42(2): 100-106.
[4]Tanaka S, Tanaka H, Abe S. High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma [J]. Chest, 2003, 124(5): 1768-1773.
[5]Vachier I, Kumlin M, Dahlēn SE, Bousquet T, Godard P, Chanez P. High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma[J]. Respir Med, 2003, 97(11): 1225-1229.
[6]Pavord ID, Ward R, Woltmann G,Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma [J]. Am J Respir Crit Care Med, 1999, 160(6): 1905-1909.
[7]Zaitsu M, Hamasaki Y, Matsuo M, Ichimaru T, Fujita I, Ishii E. Leukotriene synthesis is increased by transcriptional up-regulation of 5lipoxygenase, leukotriene A4 hydrolase, and leukotriene C4 synthase in asthmatic children [J]. J Asthma, 2003, 40(2): 147-154.
[8]Taylor GW, Taylor I, Black P, Maltby NH, Turner N, Fuller RW, et al. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis [J]. Lancet, 1989, 1(8638):584-588.
[9]Westcott JY, Smith HR, Wenzel SE, Larsen GL, Thomas RB, Felsien D. Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate [J]. Am Rev Respir Dis, 1991, 143(6): 1322-1328.
[10]Asano K, Lilly CM, O′Donnell WJ, Israel E, Fischer A, Ransil BJ, et al. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma [J].J Allergy Clin Immunol, 1995, 96(5 Pt 1):643-651.
[11]Piedimonte G, Renzetti G, Auais A, Pi Marro A, Tripodi S, Golistro F, et al. Leukotriene synthesis during respiratory syncytial virus bronchiolitis:influence of age and atopy [J]. Pediatr Pulmonol, 2005, 40(4):285-291.
[12]Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC,et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma [J]. J Allergy Clin Immunol, 2005, 115(2):233-242.

PDF(1037 KB)

Accesses

Citation

Detail

Sections
Recommended

/